What if you'd held NERV?
A $1,000 investment in Minerva Neurosciences, Inc (NERV) at the month-end close of 2014-07 would be worth $87.76 at the close of 2026-09 — -91.2% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $4,938.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2014
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2014 | $1,000 | — |
| 2015 | $1,008 | +0.8% |
| 2016 | $1,952 | +93.6% |
| 2017 | $1,005 | -48.5% |
| 2018 | $1,120 | +11.4% |
| 2019 | $1,181 | +5.5% |
| 2020 | $389 | -67.1% |
| 2021 | $133 | -65.8% |
| 2022 | $33.01 | -75.2% |
| 2023 | $128 | +286.8% |
| 2024 | $46.10 | -63.9% |
| 2025 | $83.47 | +81.1% |
| 2026 | $91.99 | +10.2% |
Best and worst month-end to buy
The best single month-end close to have bought NERV was 2025-05 ($1.54): $1,000 then is $2,877 today. The worst was 2016-09 ($113): $1,000 then is $39.23.
FAQ
What would $1,000 in NERV be worth today?
A $1,000 investment in Minerva Neurosciences, Inc (NERV) at the start of 2014 would be worth about $87.76 today, a total return of -91.2%. Dividends are reinvested in these figures.
What were the best and worst years for NERV?
Minerva Neurosciences, Inc (NERV)'s strongest calendar year since 2014 was 2023, a +286.8% return — $1,000 held through that year became about $3,868 by year-end. Its weakest year was 2022, at -75.2%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in NERV have grown?
Investing $100 at the end of every month since 2014-07 would have grown to about $9,063 on $14,700 invested.
Did NERV beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $4,938. NERV trailed the S&P 500 by +98.2% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Minerva Neurosciences, Inc (NERV) historical total-return data from 2014-07 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.